Evidence map›Paper›PMID 39229276›Full record

ArticleFrontiers in immunology2024

Comprehensive landscapes of the causal network between immunity and sarcopenia.

Mingchong Liu, Jiaming Wang, Yi Han, Xiao Fu, Yutao Pan, Chensong Yang, Guixin Sun

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mingchong LiuDepartment of Traumatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Jiaming WangDepartment of Traumatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Yi HanDepartment of Traumatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Xiao FuDepartment of Traumatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Yutao PanDepartment of Traumatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Chensong YangDepartment of Traumatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Guixin SunDepartment of Traumatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inflammaging, an immune status characterized by a sustained increase in pro-inflammatory markers and a decline in anti-inflammatory mechanisms, is a critical risk factor in the development of sarcopenia. Landscapes of the causal relationships between immunity and sarcopenia are needed to understand the mechanism of sarcopenia and provide novel treatments comprehensively. Methods: We used Mendelian Randomization (MR) as the basic method in this study. By setting immune proteins, immune cells, and sarcopenia as exposures and outcomes alternatively, and then combining them in different directions, we potentially estimated their causal relationships and directions and subsequently mapped the comprehensive causal landscape based on this information efficiently. To further understand the network, we developed a method based on rank-sums to integrate multiple algorithms and identify the key immune cells and proteins. Results: More than 1,000 causal relationships were identified between immune cell phenotypes, proteins, and sarcopenia traits (p < 0.05), and the causal maps of these linkages were established. In the threshold of FDR < 0.05, hundreds of causal linkages were still significant. The final comprehensive map included 13 immune cell phenotypes and 8 immune proteins. The star factors in the final map included EM CD8br %CD8br, EM DN (CD4- CD8-) %DN, SIRT2, and so on. Conclusion: By reading the landscapes in this study, we may not only find the factors and the pathways that have been reported and proven but also identify multiple novel immunity cell phenotypes and proteins with enriched upstream and downstream pathways.

Indexed as

SarcopeniaHumansImmunityMendelian Randomization Analysisimmune cell phenotypesimmune factorsMendelian randomizationnetwork analysissarcopenia

Identifiers

PMID39229276
PMCPMC11368746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.